Table 1.
Baseline characteristics in 270 patients (mean±SD).
| Variable factors | All patients (n = 270) | Recurrent patients (n = 136) |
Recurrent patients (n = 136) |
|
| Early phase (n = 107) | Late phase (n = 29) | |||
| Age (yr) | 46.9±13.0 | 4.0±11.5 | 44.2±11.1 | 47.7±12.9 |
| Sex (male/female) | 247/23 | 126/10 | Aug-99 | 27/2 |
| Gross tumorclassification (small/solitary/nodular) | 66/168/36 | 35/77/24 | 23/63/21 | 12/14/3 |
| Edmondson classification (I-II/III-IV) | 128/142 | 65/71 | 46/61 | 19/10 |
| Tumor capsule (present/absent) | 55/215 | 23/113 | 13/94 | 10/19 |
| Vascular invasion (present/absent) | 145/125 | 79/57 | 62/45 | 7/12 |
| Alpha-fetoprotein (positive/negative) | 141/129 | 85/51 | 75/32 | 10/19 |
| Hepatocirrhosis (positive/negative) | 200/70 | 105/31 | 82/25 | 23/6 |
| Type of liver resection (non-anatomical/anatomical) | 149/121 | 78/58 | 59/48 | 19/10 |
| Incisal margin (≤1 cm/>1 cm) | 22/258 | 15/131 | 14/93 | 1/28 |
| HBV infection (positive/negative) | 239/31 | 128/8 | 102/5 | 26/3 |
| Blood transfusion (yes/no) | 199/71 | 100/36 | 75/32 | 25/4 |
| Survival time (d) | – | 575.9±499.6 | 384.7±313.1 | 1248.5±450.9 |
| Recurrent time (d) | – | 435.6±417.9 | 23.1±199.6 | 1072.2±396.9 |
Note: Small HCC (SHCC), solitary large HCC (SLHCC), nodular HCC (NHCC).